| Ronald G Beebe, MD | |
|
950 S Enota Dr Ne, Gainesville, GA 30501 | |
| (770) 536-0470 | |
| (770) 536-3031 |
| Full Name | Ronald G Beebe |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 38 Years |
| Location | 950 S Enota Dr Ne, Gainesville, Georgia |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760445852 | NPI | - | NPPES |
| 000353075L | Medicaid | GA | |
| 000353075N | Medicaid | GA | |
| 000353075J | Medicaid | GA | |
| 52029274 | Other | GA | BCBS |
| 000353075I | Medicaid | GA | |
| 000353075K | Medicaid | GA | |
| P00897212 | Other | GA | RAILROAD MEDICARE |
| 0811620 | Other | GA | CIGNA |
| 584715 | Other | GA | WELLCARE OF GEORGIA |
| D44835 | Other | GA | MEDICARE |
| 01389421 | Other | GA | AMERIGROUP |
| 000353075M | Medicaid | GA | |
| 1246699 | Other | GA | COVENTRY |
| 584715 | Other | GA | WELLCARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 030006 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pruitthealth Hospice-gainesville | Gainesville, GA | Hospice |
| Northeast Georgia Medical Center, Inc | Gainesville, GA | Hospital |
| Willowbrooke Court At Lanier Village Estates | Gainesville, GA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Atlanta Allergy And Asthma Pa | 1254372006 | 40 |
News Archive
Research on an aerosol that jump-starts a rapid immune response to stifle viral respiratory infections before they can provoke asthma attacks has earned major funding from the National Institutes of Health.
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today it has entered into an agreement with VHA Inc., a national health care network serving 1,400 not-for-profit hospitals and 30,000 non-acute care providers across the nation.
Teva Pharmaceutical Industries Ltd. and OncoGenex Pharmaceuticals, Inc. announced today that they have entered into a global license and collaboration agreement to develop and commercialize OGX-011, as well as an agreement to purchase shares in OncoGenex. OGX-011 is a Phase III cancer therapy designed to inhibit cancer treatment resistance.
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that TF12, in combination with radiolabeled peptides, produced specific, fast, high-contrast imaging and pretargeted radioimmunotherapy of epithelial cancers that include cancers of the prostate and the ovary.
HP and African social enterprise mPedigree Network have introduced a potentially life-saving service that targets counterfeit pharmaceuticals by enabling people in Nigeria and Ghana to easily check the authenticity of their malaria medication.
› Verified 4 days ago
| Entity Name | Atlanta Allergy & Asthma Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598796195 PECOS PAC ID: 1254372006 Enrollment ID: O20050523000011 |
News Archive
Research on an aerosol that jump-starts a rapid immune response to stifle viral respiratory infections before they can provoke asthma attacks has earned major funding from the National Institutes of Health.
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today it has entered into an agreement with VHA Inc., a national health care network serving 1,400 not-for-profit hospitals and 30,000 non-acute care providers across the nation.
Teva Pharmaceutical Industries Ltd. and OncoGenex Pharmaceuticals, Inc. announced today that they have entered into a global license and collaboration agreement to develop and commercialize OGX-011, as well as an agreement to purchase shares in OncoGenex. OGX-011 is a Phase III cancer therapy designed to inhibit cancer treatment resistance.
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that TF12, in combination with radiolabeled peptides, produced specific, fast, high-contrast imaging and pretargeted radioimmunotherapy of epithelial cancers that include cancers of the prostate and the ovary.
HP and African social enterprise mPedigree Network have introduced a potentially life-saving service that targets counterfeit pharmaceuticals by enabling people in Nigeria and Ghana to easily check the authenticity of their malaria medication.
› Verified 4 days ago
| Entity Name | Breathe Better Allergy Asthma & Sinus Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821567371 PECOS PAC ID: 4688910631 Enrollment ID: O20190111000676 |
News Archive
Research on an aerosol that jump-starts a rapid immune response to stifle viral respiratory infections before they can provoke asthma attacks has earned major funding from the National Institutes of Health.
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today it has entered into an agreement with VHA Inc., a national health care network serving 1,400 not-for-profit hospitals and 30,000 non-acute care providers across the nation.
Teva Pharmaceutical Industries Ltd. and OncoGenex Pharmaceuticals, Inc. announced today that they have entered into a global license and collaboration agreement to develop and commercialize OGX-011, as well as an agreement to purchase shares in OncoGenex. OGX-011 is a Phase III cancer therapy designed to inhibit cancer treatment resistance.
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that TF12, in combination with radiolabeled peptides, produced specific, fast, high-contrast imaging and pretargeted radioimmunotherapy of epithelial cancers that include cancers of the prostate and the ovary.
HP and African social enterprise mPedigree Network have introduced a potentially life-saving service that targets counterfeit pharmaceuticals by enabling people in Nigeria and Ghana to easily check the authenticity of their malaria medication.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ronald G Beebe, MD 950 S Enota Dr Ne, Gainesville, GA 30501-2413 Ph: (770) 536-0470 | Ronald G Beebe, MD 950 S Enota Dr Ne, Gainesville, GA 30501 Ph: (770) 536-0470 |
News Archive
Research on an aerosol that jump-starts a rapid immune response to stifle viral respiratory infections before they can provoke asthma attacks has earned major funding from the National Institutes of Health.
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today it has entered into an agreement with VHA Inc., a national health care network serving 1,400 not-for-profit hospitals and 30,000 non-acute care providers across the nation.
Teva Pharmaceutical Industries Ltd. and OncoGenex Pharmaceuticals, Inc. announced today that they have entered into a global license and collaboration agreement to develop and commercialize OGX-011, as well as an agreement to purchase shares in OncoGenex. OGX-011 is a Phase III cancer therapy designed to inhibit cancer treatment resistance.
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that TF12, in combination with radiolabeled peptides, produced specific, fast, high-contrast imaging and pretargeted radioimmunotherapy of epithelial cancers that include cancers of the prostate and the ovary.
HP and African social enterprise mPedigree Network have introduced a potentially life-saving service that targets counterfeit pharmaceuticals by enabling people in Nigeria and Ghana to easily check the authenticity of their malaria medication.
› Verified 4 days ago
Miss Faria Memnum Khan, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2510 Limestone Pkwy, Gainesville, GA 30501 Phone: 770-219-9500 | |
Dr. Amy Whitmire Boyd, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 528 Broad St Se Ste B, Gainesville, GA 30501 Phone: 770-534-0534 Fax: 770-718-0741 | |
William A Nish, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2510 Limestone Pkwy, Gainesville, GA 30501 Phone: 770-534-9933 Fax: 770-534-8999 | |
Michael James Maloney, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 100 College Ave Se, Gainesville, GA 30501 Phone: 678-971-5005 Fax: 678-971-5009 |